Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV+ Patients”

Showing 20 of 0 results

Not applicableStudy completedNCT00904384
What this trial is testing

Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients

Who this might be right for
HIV InfectionsCOPD
Cimera 350
Testing effectiveness (Phase 2)Study completedNCT00184951
What this trial is testing

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Who this might be right for
HIV InfectionsHyperlipidemia
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT01549119
What this trial is testing

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

Who this might be right for
HIV-1 Infection
InnaVirVax 33
Post-approval studies (Phase 4)Study completedNCT00119769
What this trial is testing

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Who this might be right for
HIV InfectionsLipodystrophy
Hvidovre University Hospital 46
Not applicableStudy completedNCT04113629
What this trial is testing

Simplified Monitoring Myanmar SM2 Study

Who this might be right for
Hepatitis CLiver CirrhosesLiver Inflammation+1 more
Kirby Institute 200
Not applicableNot Yet RecruitingNCT06403865
What this trial is testing

Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Who this might be right for
Quality of Life
University Paris 7 - Denis Diderot 280
Testing effectiveness (Phase 2)Study completedNCT00002412
What this trial is testing

MKC-442 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Not applicableUnknownNCT03123575
What this trial is testing

Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV
Hospital General Universitario Gregorio Marañon 1,000
Early research (Phase 1)Study completedNCT00261001
What this trial is testing

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Who this might be right for
Healthy VolunteersHIV Infection
Objectif Recherche Vaccins SIDA 38
Large-scale testing (Phase 3)Study completedNCT02041520
What this trial is testing

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

Who this might be right for
HIV/AIDS
Coordinación de Investigación en Salud, Mexico 70
Large-scale testing (Phase 3)Study completedNCT01608802
What this trial is testing

Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care

Who this might be right for
HIV
King's College London 240
Large-scale testing (Phase 3)Ended earlyNCT00004986
What this trial is testing

Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

Who this might be right for
CryptosporidiosisHIV Infections
Romark Laboratories L.C. 30
Not applicableLooking for participantsNCT06934369
What this trial is testing

Improving Engagement in HIV and Cancer Care in Zimbabwe

Who this might be right for
CancerHIV
Fred Hutchinson Cancer Center 300
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00056641
What this trial is testing

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 328
Not applicableWithdrawnNCT03405194
What this trial is testing

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Who this might be right for
HIV/AIDS
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Post-approval studies (Phase 4)Study completedNCT00402454
What this trial is testing

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Who this might be right for
HIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 300
Not applicableStudy completedNCT01942005
What this trial is testing

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients

Who this might be right for
ImmunosuppressionNeoplasm
Andreas Arnold 144
Large-scale testing (Phase 3)Study completedNCT00421551
What this trial is testing

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 225
Not applicableStudy completedNCT00002029
What this trial is testing

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

Who this might be right for
HIV Infections
Abbott
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation